Morgan Stanley upgrades Klaviyo stock rating to Overweight on multi-product expansion

Morgan Stanley upgraded Klaviyo Inc (KVYO) to Overweight with a $50 price target, citing the company's strategic expansion into a multi-product platform beyond email marketing, which is expected to drive durable revenue growth exceeding 20% over the next three years. The firm deems KVYO's current valuation of approximately 6x enterprise value to sales as "too cheap" given its robust financial performance, including 33.17% LTM revenue growth and 75.42% gross margins, despite a 40% multiple compression year-to-date. This positive outlook is reinforced by strong Q2 results that led to raised FY25 guidance, though a major shareholder, Summit Partners, plans to sell 6.5 million shares, from which Klaviyo will not receive proceeds.

Analysis

Klaviyo Inc. (KVYO) has received a significant vote of confidence from Morgan Stanley, which upgraded the stock to Overweight and raised its price target to $50, citing a strategic evolution from a single-product email service to a multi-product platform incorporating marketing, customer service, and analytics. This shift is projected to fuel durable revenue growth exceeding 20% over the next three years. This bullish outlook is substantiated by the company's recent performance, including a 33.17% revenue increase over the last twelve months and impressive gross margins of 75.42%. The valuation appears compelling, with the stock trading at approximately 6x enterprise value to sales, a level deemed "too cheap" by Morgan Stanley, especially after a 40% multiple compression year-to-date, which is drastically steeper than the 2% moderation in the broader SaaS sector. This valuation discount exists despite consistently strong results, such as the recent Q2 revenue growth of 32% (beating 26% estimates) and a subsequent upgrade to its FY25 growth guidance to 27-28%. Other analysts, including TD Cowen and Piper Sandler, have also raised their price targets. Counterbalancing this optimism are two key developments: a planned secondary offering of 6.5 million shares by major shareholder Summit Partners, from which Klaviyo will receive no proceeds, and the appointment of an interim executive officer through December 2025.

Key Decisions for Investors

• Given the strong analyst upgrades, robust fundamental growth, and a valuation that appears disconnected from both its performance and SaaS peers, investors may view the current share price as a compelling entry point.
• It is crucial to monitor the market's absorption of the 6.5 million shares being sold by Summit Partners, as this secondary offering could create a near-term supply overhang and price volatility, even though it does not impact the company's cash position.
• The investment thesis hinges on the successful execution of the multi-product strategy and subsequent margin recovery; investors should therefore track key performance indicators like average revenue per user and operating margins in future earnings reports.
• The appointment of an interim executive officer introduces leadership uncertainty, warranting observation for any potential shifts in strategic direction or execution through the end of 2025.